Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers
Clinical trial NCT07126561 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07126561
- Sponsor
- University of Chicago
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-01
- Primary completion
- 2028-11-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.